George Church – Professor of Genetics, Harvard Medical School
George Church’s 1984 Harvard PhD included the first direct genomic sequencing method, molecular multiplexing tags, which lead to automation & software used at Genome Therapeutics Corp. for the first commercial genome sequence — pathogen, Helicobacter in 1994. This multiplex solid-phase sequencing evolved into polonies (1999), ABI-SOLiD (2005) & open-source Polonator.org (2007). Innovations in DNA reading, writing & allele replacement in cells lead to current research & commercialization in human genomics (Complete Genomics, PersonalGenomes.org, 23andme, Knome) , synthetic biology (SynBERC, Joule, LS9) & new ethics/security strategies.
Robert Dobkin – CTO & VP of Engineering, Linear Technology
Robert C. Dobkin is a Co-founder of Linear Technology Corp. and has been its Vice President of Engineering and Chief Technical Officer since April 1999. He served as Vice President of Engineering of Linear Technology Corp., from September 1981 to April 1999. From January 1969 to July 1981, Mr. Dobkin was employed in various positions at National. He has extensive experience in linear circuit design with over 100 patents.  Mr. Dobkin attended the Massachusetts Institute of Technology.
David Fullagar – Founder, Maxim Integrated Products
David Fullagar was a Co-founder and Vice President of R&D at Maxim Integrated Products, a leading supplier of analog & mixed signal semiconductors, until he retired in 1999. Prior to that, he held various positions at Intersil, including Director of European Applications and Vice President of Engineering. David began his semiconductor career at Fairchild in the mid 1960s and developed some of that company’s industry-standard operational amplifiers. He emigrated from England to the US in 1965. He is a graduate of Trinity College, Cambridge and has a BA in Physics and an MSEE.
Sean George – Founder & CEO, Locus Development
Dr. George has held a number of executive management positions in the life science industry.  Prior to founding Locus, he was COO at Navigenics, a leading consumer genetics company.  Dr. George has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen.  In the past, he has also worked at Molecular Probes and McKinsey Consulting.  Dr. George holds a BS in Molecular Genetics from UCLA, an MS in Molecular Biology from UC Santa Barbara, and a PhD in Molecular Genetics from UC Santa Cruz.
Eran Halperin – Senior Research Scientist at the International Computer Science Institute, Berkeley, Director of the Center for Computational Genetics
Dr. Halperin is a principal investigator in the International Computer Science Institute (ICSI) in Berkeley, California and an Associate Professor at Tel-Aviv University. His group has developed methods that have been used by thousands of researchers worldwide to understand the genetic causes of diseases such as cardiovascular diseases, non-Hodgkin’s lymphoma, and breast cancer. Dr. Halperin has published more than 80 peer-reviewed articles across different disciplines including human genetics, computational biology, computer science, and operations research. He received various honors for academic achievements, including the Rothschild Fellowship, the Intel, and the Krill prizes. Dr. Halperin received his Ph.D. in computer science from Tel-Aviv University.
Dietrich Stephan – Founder, President & CEO, Ignite Institute
Dr. Stephan has founded a number of companies, including Navigenics, Amnestix and Aeuon, Inc. Prior to this, Dr. Stephan served as a founding Chairman of the Department of Neurogenomics and Deputy Director of the non-profit Translational Genomics Research Institute (TGen).  Dr. Stephan is currently chairman of the National Institutes of Health (NIH) Neuroscience Microarray Consortium, and Executive Director of the Gene Partnership at Harvard Medical School.  He received his B.S. at Carnegie-Mellon University and his Ph.D. at the University of Pittsburgh, and trained as a fellow at the National Human Genome Research Institute of the NIH. He is a Director of the Personalized Medicine Coalition, SAGE BioNetworks, and vaBIO.